Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease

被引:85
|
作者
Fernandez-Prado, Raul [1 ]
Esteras, Raquel [1 ]
Vanessa Perez-Gomez, Maria [1 ]
Gracia-Iguacel, Carolina [1 ]
Gonzalez-Parra, Emilio [1 ]
Sanz, Ana B. [1 ]
Ortiz, Alberto [1 ]
Dolores Sanchez-Nino, Maria [1 ]
机构
[1] Univ Autonoma Madrid, Fdn Jimenez Diaz, IIS, Madrid 28040, Spain
关键词
chronic kidney disease; caramboxin; microbiota; choline; carnitine; tryptophan; tyrosine; trimethylamine N-Oxide (TMAO); p-cresyl sulfate; indoxyl sulfate; gut-kidney axis; TRIMETHYLAMINE-N-OXIDE; P-CRESYL SULFATE; ARYL-HYDROCARBON RECEPTOR; BOUND UREMIC TOXINS; PLASMA CHOLINE CONCENTRATIONS; ORAL L-CARNITINE; INDOXYL SULFATE; GUT MICROBIOTA; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE;
D O I
10.3390/nu9050489
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
In chronic kidney disease (CKD), accumulation of uremic toxins is associated with an increased risk of death. Some uremic toxins are ingested with the diet, such as phosphate and star fruit-derived caramboxin. Others result from nutrient processing by gut microbiota, yielding precursors of uremic toxins or uremic toxins themselves. These nutrients include L-carnitine, choline/phosphatidylcholine, tryptophan and tyrosine, which are also sold over-the-counter as nutritional supplements. Physicians and patients alike should be aware that, in CKD patients, the use of these supplements may lead to potentially toxic effects. Unfortunately, most patients with CKD are not aware of their condition. Some of the dietary components may modify the gut microbiota, increasing the number of bacteria that process them to yield uremic toxins, such as trimethylamine N-Oxide (TMAO), p-cresyl sulfate, indoxyl sulfate and indole-3 acetic acid. Circulating levels of nutrient-derived uremic toxins are associated to increased risk of death and cardiovascular disease and there is evidence that this association may be causal. Future developments may include maneuvers to modify gut processing or absorption of these nutrients or derivatives to improve CKD patient outcomes.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression
    Castillo-Rodriguez, Esmeralda
    Fernandez-Prado, Raul
    Esteras, Raquel
    Vanessa Perez-Gomez, Maria
    Gracia-Iguacel, Carolina
    Fernandez-Fernandez, Beatriz
    Kanbay, Mehmet
    Tejedor, Alberto
    Lazaro, Alberto
    Ruiz-Ortega, Marta
    Gonzalez-Parra, Emilio
    Sanz, Ana B.
    Ortiz, Alberto
    Dolores Sanchez-Nino, Maria
    TOXINS, 2018, 10 (07)
  • [2] Gut microbiota in chronic kidney disease
    Cigarran Guldris, Secundino
    Gonzalez Parra, Emilio
    Cases Amenos, Aleix
    NEFROLOGIA, 2017, 37 (01): : 9 - 19
  • [3] The gut microbiota and its relationship with chronic kidney disease
    Plata, Consuelo
    Cruz, Cristino
    Cervantes, Luz G.
    Ramirez, Victoria
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (12) : 2209 - 2226
  • [4] Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease
    Chermiti, Rania
    Burtey, Stephane
    Dou, Laetitia
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [5] Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model
    Mishima, Eikan
    Fukuda, Shinji
    Kanemitsu, Yoshitomi
    Saigusa, Daisuke
    Mukawa, Chikahisa
    Asaji, Kei
    Matsumoto, Yotaro
    Tsukamoto, Hiroki
    Tachikawa, Tatsuki
    Tsukimi, Tomoya
    Fukuda, Noriko N.
    Ho, Hsin-Jung
    Kikuchi, Koichi
    Suzuki, Chitose
    Nanto, Fumika
    Suzuki, Takehiro
    Ito, Sadayoshi
    Soga, Tomoyoshi
    Tomioka, Yoshihisa
    Abe, Takaaki
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 315 (04) : F824 - F833
  • [6] The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
    Huang, Yinghui
    Xin, Wang
    Xiong, Jiachuan
    Yao, Mengying
    Zhang, Bo
    Zhao, Jinghong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Homeostasis in the Gut Microbiota in Chronic Kidney Disease
    Bhargava, Shruti
    Merckelbach, Erik
    Noels, Heidi
    Vohra, Ashima
    Jankowski, Joachim
    TOXINS, 2022, 14 (10)
  • [8] Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
    Pan, Libin
    Yu, Hang
    Fu, Jie
    Hu, Jiachun
    Xu, Hui
    Zhang, Zhengwei
    Bu, Mengmeng
    Yang, Xinyu
    Zhang, Haojian
    Lu, Jinyue
    Jiang, Jiandong
    Wang, Yan
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (04) : 1537 - 1553
  • [9] Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease
    Mafra, Denise
    Lobo, Julie C.
    Barros, Amanda F.
    Koppe, Laetitia
    Vaziri, Nosratola D.
    Fouque, Denis
    FUTURE MICROBIOLOGY, 2014, 9 (03) : 399 - 410
  • [10] The impact of dietary nutrient intake on gut microbiota in the progression and complications of chronic kidney disease
    Koppe, Laetitia
    Soulage, Christophe O.
    KIDNEY INTERNATIONAL, 2022, 102 (04) : 728 - 739